Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +80.9% | +68.5% | 3 / 3 | -23.1% | +63.49 pp | +80.72 pp | -84.1% | 1.71 | — | 4,3 | −23,1% | −1,1 | +80,9% | — | -1.15 | — |
| Pts | 12 | 12 | 12 | 0 | 12 | 12 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 900,0 (close price on 2026-10-19)EPS (TTM): −434,7
Financial charts
1.Revenue & growth
VND bn4,28Q2/26
1.Revenue & growth
VND bn4,28Q2/26
2.Profit & growth
VND bn-1,14Q2/26
3.Profit mix (Penman)
VND bn-15,1Q2/26
4.Margins & cost structure
%-55.0%Q2/26
5.Returns & cash cycle
% · days-31.3%Q2/26
6.Earnings quality & cash
VND bn-9,08Q2/26
7.Asset structure
VND bn47,3Q2/26
8.Funding & debt health
VND bn · times47,3Q2/26
9.Revenue backlog
VND bn0,52Q2/26
10.Valuation
times · %-1,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-33Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26